• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP Back to Search Results
Catalog Number PAJ062502
Device Problem Failure to Unfold or Unwrap (1669)
Patient Problem Perforation of Vessels (2135)
Event Date 02/27/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
The following information was reported to gore: on (b)(6) 2018 a patient was undergoing treatment of a superficial femoral artery occlusion with a gore® viabahn® endoprosthesis with propaten bioactive surface.The lesion was pre-dilated with a pta balloon.The gore® viabahn® endoprosthesis with propaten bioactive surface was advanced over a wire through a short 6fr sheath and positioned for deployment.Device deployment was initiated.Approximately one third of the deployment line was pulled when the deployment line became stuck, and deployment would not continue.The endoprosthesis was expanded halfway at this point.Deployment was attempted again, but was not successful.The procedure was converted to cut down with open repair under general anesthesia to remove the partially expanded endoprosthesis from the vessel.The patient did well following the open repair.
 
Manufacturer Narrative
The engineering evaluation stated the following: an introducer sheath was returned but was not evaluated as it is not a gore product.Approximately 56 cm of deployment line connected the hub to the deployment knob.The endoprosthesis appeared compressed towards the tip end of the device.There was 7 cm of exposed distal shaft, upon which the endoprosthesis is mounted, at the transition.The endoprosthesis was partially expanded a total of 4 cm at the tip end.There was also partial expansion at 5.5, 6, and 19 cm from the tip end of the endoprosthesis.The deployment line nearest to the 4 cm of partial expansion appeared normal at 9 cm from the tip end of the device there is a single fiber from the deployment line that was looped around the constrained endoprosthesis.At 11 cm from the transition end, there were broken fibers.Based on the device examination performed, no manufacturing anomalies were identified.
 
Event Description
On (b)(6) 2018 a patient was undergoing treatment of a superficial femoral artery occlusion with a gore® viabahn® endoprosthesis with propaten bioactive surface.The lesion was pre-dilated with a pta balloon.The gore® viabahn® endoprosthesis with propaten bioactive surface was advanced over a wire through a short 6fr sheath and positioned for deployment.Device deployment was initiated.Approximately one third of the deployment line was pulled when the deployment line became stuck, and deployment would not continue.The endoprosthesis was expanded halfway at this point.Deployment was attempted again, but was not successful.The procedure was converted to cut down with open repair under general anesthesia to remove the partially expanded endoprosthesis from the vessel.Three abbott eluvia stents were implanted and post-ballooned to complete the procedure.The patient did well following the open repair.Three weeks postoperatively the patient was doing very well with no further issues or complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
heidi inskeep
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7366391
MDR Text Key103332948
Report Number2017233-2018-00184
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/08/2020
Device Catalogue NumberPAJ062502
Device Lot Number17220345
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/14/2018
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/23/2018
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/18/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/09/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age65 YR
-
-